These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 28134678)

  • 1. What is new in the management of skin and soft tissue infections in 2016?
    Poulakou G; Giannitsioti E; Tsiodras S
    Curr Opin Infect Dis; 2017 Apr; 30(2):158-171. PubMed ID: 28134678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in prescriptive practices in skin and soft tissue infections associated with the increased occurrence of community acquired methicillin resistant Staphylococcus aureus.
    Meddles-Torres C; Hu S; Jurgens C
    J Infect Public Health; 2013 Dec; 6(6):423-30. PubMed ID: 23999333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New drugs for methicillin-resistant Staphylococcus aureus skin and soft tissue infections.
    Hindy JR; Haddad SF; Kanj SS
    Curr Opin Infect Dis; 2022 Apr; 35(2):112-119. PubMed ID: 34812745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. What's new in the epidemiology of skin and soft tissue infections in 2018?
    Poulakou G; Lagou S; Tsiodras S
    Curr Opin Infect Dis; 2019 Apr; 32(2):77-86. PubMed ID: 30664027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Newer treatment options for skin and soft tissue infections.
    Raghavan M; Linden PK
    Drugs; 2004; 64(15):1621-42. PubMed ID: 15257625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A prospective observational cohort study in primary care practices to identify factors associated with treatment failure in Staphylococcus aureus skin and soft tissue infections.
    Lee GC; Hall RG; Boyd NK; Dallas SD; Du LC; Treviño LB; Treviño SB; Retzloff C; Lawson KA; Wilson J; Olsen RJ; Wang Y; Frei CR
    Ann Clin Microbiol Antimicrob; 2016 Nov; 15(1):58. PubMed ID: 27876059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increasing incidence of methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: reconsideration of empiric antimicrobial therapy.
    Awad SS; Elhabash SI; Lee L; Farrow B; Berger DH
    Am J Surg; 2007 Nov; 194(5):606-10. PubMed ID: 17936421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin and soft-tissue infections: a critical review and the role of telavancin in their treatment.
    Cardona AF; Wilson SE
    Clin Infect Dis; 2015 Sep; 61 Suppl 2():S69-78. PubMed ID: 26316560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of dalbavancin in skin and soft tissue infections.
    Bassetti M; Peghin M; Carnelutti A; Righi E
    Curr Opin Infect Dis; 2018 Apr; 31(2):141-147. PubMed ID: 29298166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Obesity and skin and soft tissue infections: how to optimize antimicrobial usage for prevention and treatment?
    Grupper M; Nicolau DP
    Curr Opin Infect Dis; 2017 Apr; 30(2):180-191. PubMed ID: 28118218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment options for uncomplicated community-acquired skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus: oral antimicrobial agents.
    Zervos M
    Surg Infect (Larchmt); 2008; 9 Suppl 1():s29-34. PubMed ID: 18844472
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Empiric antimicrobial therapy for pediatric skin and soft-tissue infections in the era of methicillin-resistant Staphylococcus aureus.
    Elliott DJ; Zaoutis TE; Troxel AB; Loh A; Keren R
    Pediatrics; 2009 Jun; 123(6):e959-66. PubMed ID: 19470525
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology, Disposition, and Treatment of Ambulatory Veterans With Skin and Soft Tissue Infections.
    Rhoads JLW; Willson TM; Sutton JD; Spivak ES; Samore MH; Stevens VW
    Clin Infect Dis; 2021 Feb; 72(4):675-681. PubMed ID: 32047886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hospitalist perspective on the treatment of skin and soft tissue infections.
    Amin AN; Cerceo EA; Deitelzweig SB; Pile JC; Rosenberg DJ; Sherman BM
    Mayo Clin Proc; 2014 Oct; 89(10):1436-51. PubMed ID: 24974260
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methicillin-resistant Staphylococcus aureus in skin and soft tissue infections presenting to the Emergency Department of a Canadian Academic Health Care Center.
    Achiam CC; Fernandes CM; McLeod SL; Salvadori MI; John M; Seabrook JA; Theakston KD; Milburn S; Hussain Z
    Eur J Emerg Med; 2011 Feb; 18(1):2-8. PubMed ID: 20168235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is methicillin-resistant Staphylococcus aureus involved in community acquired skin and soft tissue infections? Experience from a tertiary care centre in Mumbai.
    Phakade RS; Nataraj G; Kuyare SS; Khopkar US; Mehta PR
    J Postgrad Med; 2012; 58(1):3-7. PubMed ID: 22387641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections.
    Bassetti M; Carnelutti A; Righi E
    Curr Opin Infect Dis; 2017 Apr; 30(2):150-157. PubMed ID: 28079631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin and soft tissue infections: the new surgical infection society guidelines.
    May AK
    Surg Infect (Larchmt); 2011 Jun; 12(3):179-84. PubMed ID: 21767156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Skin and soft tissue infections caused by methicillin-resistant Staphylococcus aureus (MRSA): an affliction of the underclass.
    Vayalumkal JV; Suh KN; Toye B; Ramotar K; Saginur R; Roth VR
    CJEM; 2012 Nov; 14(6):335-43. PubMed ID: 23131480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Community-associated methicillin-resistant Staphylococcus aureus skin and soft-tissue infection in HIV-infected patients.
    Trinh TT; Short WR; Mermel LA
    J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):176-80. PubMed ID: 19423878
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.